Molecular Plasticity of Crystalline CK2α' Leads to KN2, a Bivalent Inhibitor of Protein Kinase CK2 with Extraordinary Selectivity

J Med Chem. 2022 Jan 27;65(2):1302-1312. doi: 10.1021/acs.jmedchem.1c00063. Epub 2021 Jul 29.

Abstract

CK2α and CK2α' are paralogous catalytic subunits of CK2, which belongs to the eukaryotic protein kinases. CK2 promotes tumorigenesis and the spread of pathogenic viruses like SARS-CoV-2 and is thus an attractive drug target. Efforts to develop selective CK2 inhibitors binding offside the ATP site had disclosed the αD pocket in CK2α; its occupation requires large conformational adaptations of the helix αD. As shown here, the αD pocket is accessible also in CK2α', where the necessary structural plasticity can be triggered with suitable ligands even in the crystalline state. A CK2α' structure with an ATP site and an αD pocket ligand guided the design of the bivalent CK2 inhibitor KN2. It binds to CK2 with low nanomolar affinity, is cell-permeable, and suppresses the intracellular phosphorylation of typical CK2 substrates. Kinase profiling revealed a high selectivity of KN2 for CK2 and emphasizes the selectivity-promoting potential of the αD pocket.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Casein Kinase II / antagonists & inhibitors*
  • Casein Kinase II / chemistry
  • Casein Kinase II / metabolism
  • Crystallization
  • HEK293 Cells
  • HeLa Cells
  • Humans
  • Ligands
  • Phosphorylation
  • Protein Conformation
  • Protein Kinase Inhibitors / pharmacology*
  • Substrate Specificity

Substances

  • Ligands
  • Protein Kinase Inhibitors
  • Adenosine Triphosphate
  • CSNK2A1 protein, human
  • Casein Kinase II